NDC 0173-0717
ADVAIR HFA
Fluticasone Propionate And Salmeterol Xinafoate
ADVAIR HFA is a Respiratory (inhalation) Aerosol, Metered in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Fluticasone Propionate; Salmeterol Xinafoate.
| Product ID | 0173-0717_296f1772-58d7-4742-abc6-4557165605b2 |
| NDC | 0173-0717 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ADVAIR HFA |
| Generic Name | Fluticasone Propionate And Salmeterol Xinafoate |
| Dosage Form | Aerosol, Metered |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2009-03-06 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021254 |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE |
| Active Ingredient Strength | 230 ug/1; ug/1 |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |